Novalyst is affiliated to AliX Pharma, a structure-based drug discovery company with expertise in protein crystallography and mass-spectrometry screening capabilities, to offer expanded discovery services.
About AliX Pharma ...www.alix-pharma.fr
AliX is a contract research organization that spun off in 2002 from the Department of Structural Biology and Genomics of IGBMC (Institute of Genetics and Molecular and Cellular Biology) in Strasbourg-Illkirch.
AliX provides pharmaceutical and biotechnology companies with X-ray crystallography services, protein purification at crystallographic grade, and ligand screening using non-covalent ESI-MS.
AliX has developed an innovative approach for fragment-based ligand design combining in-silico screening, non-covalent mass spectrometry, and X-ray crystallography to assist customers in their drug discovery programs.
|
